Aimei Vacin BioPharm (Zhejiang) Co., Ltd.
Quick facts
Phase 3 pipeline
- control pneumococcal polysaccharide vaccine · Immunology
This vaccine works by stimulating the body's immune system to produce antibodies against pneumococcal bacteria.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Aimei Vacin BioPharm (Zhejiang) Co., Ltd. portfolio CI brief
- Aimei Vacin BioPharm (Zhejiang) Co., Ltd. pipeline updates RSS
Frequently asked questions about Aimei Vacin BioPharm (Zhejiang) Co., Ltd.
What is Aimei Vacin BioPharm (Zhejiang) Co., Ltd.'s pipeline?
Aimei Vacin BioPharm (Zhejiang) Co., Ltd. has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include control pneumococcal polysaccharide vaccine.
Related
- Sector hub: All tracked pharma companies